These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 29424300)

  • 1. Targeting the Folate Receptor: Improving Efficacy in Inorganic Medicinal Chemistry.
    Carron PM; Crowley A; O'Shea D; McCann M; Howe O; Hunt M; Devereux M
    Curr Med Chem; 2018; 25(23):2675-2708. PubMed ID: 29424300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folate-mediated chemotherapy and diagnostics: An updated review and outlook.
    Xu L; Bai Q; Zhang X; Yang H
    J Control Release; 2017 Apr; 252():73-82. PubMed ID: 28235591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted poly (L-γ-glutamyl glutamine) nanoparticles of docetaxel against folate over-expressed breast cancer cells.
    Tavassolian F; Kamalinia G; Rouhani H; Amini M; Ostad SN; Khoshayand MR; Atyabi F; Tehrani MR; Dinarvand R
    Int J Pharm; 2014 Jun; 467(1-2):123-38. PubMed ID: 24680951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Folate receptor-mediated drug targeting: from therapeutics to diagnostics.
    Hilgenbrink AR; Low PS
    J Pharm Sci; 2005 Oct; 94(10):2135-46. PubMed ID: 16136558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carboxymethyl-β-cyclodextrin conjugated nanoparticles facilitate therapy for folate receptor-positive tumor with the mediation of folic acid.
    Su C; Li H; Shi Y; Wang G; Liu L; Zhao L; Su R
    Int J Pharm; 2014 Oct; 474(1-2):202-11. PubMed ID: 25149123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In search of the Holy Grail: Folate-targeted nanoparticles for cancer therapy.
    Garcia-Bennett A; Nees M; Fadeel B
    Biochem Pharmacol; 2011 Apr; 81(8):976-84. PubMed ID: 21300030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Folate based radiopharmaceuticals for imaging and therapy of cancer and inflammation.
    Muller C
    Curr Pharm Des; 2012; 18(8):1058-83. PubMed ID: 22272825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery and development of folic-acid-based receptor targeting for imaging and therapy of cancer and inflammatory diseases.
    Low PS; Henne WA; Doorneweerd DD
    Acc Chem Res; 2008 Jan; 41(1):120-9. PubMed ID: 17655275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Folate-mediated targeting of antineoplastic drugs, imaging agents, and nucleic acids to cancer cells.
    Wang S; Low PS
    J Control Release; 1998 Apr; 53(1-3):39-48. PubMed ID: 9741912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regioselective synthesis of folate receptor-targeted agents derived from epothilone analogs and folic acid.
    Vlahov IR; Vite GD; Kleindl PJ; Wang Y; Santhapuram HK; You F; Howard SJ; Kim SH; Lee FF; Leamon CP
    Bioorg Med Chem Lett; 2010 Aug; 20(15):4578-81. PubMed ID: 20594844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Engineering folate-drug conjugates to target cancer: from chemistry to clinic.
    Vlahov IR; Leamon CP
    Bioconjug Chem; 2012 Jul; 23(7):1357-69. PubMed ID: 22667324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of in vivo disulfide-reduction mediated drug release in mouse kidneys.
    Yang JJ; Kularatne SA; Chen X; Low PS; Wang E
    Mol Pharm; 2012 Feb; 9(2):310-7. PubMed ID: 22171616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imaging the folate receptor on cancer cells with 99mTc-etarfolatide: properties, clinical use, and future potential of folate receptor imaging.
    Maurer AH; Elsinga P; Fanti S; Nguyen B; Oyen WJ; Weber WA
    J Nucl Med; 2014 May; 55(5):701-4. PubMed ID: 24732155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Folate receptor and its application in the selective receptor-mediated targeting therapy of tumor cells--review].
    Gao XN; Tang SQ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Oct; 13(5):911-4. PubMed ID: 16277870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Size of single-wall carbon nanotube affects the folate receptor-mediated cancer cell targeting.
    Charbgoo F; Nikkhah M; Behmanesh M
    Biotechnol Appl Biochem; 2018 May; 65(3):328-337. PubMed ID: 28857275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Theranostic Nanoparticles Loaded with Imaging Probes and Rubrocurcumin for Combined Cancer Therapy by Folate Receptor Targeting.
    Alberti D; Protti N; Franck M; Stefania R; Bortolussi S; Altieri S; Deagostino A; Aime S; Geninatti Crich S
    ChemMedChem; 2017 Apr; 12(7):502-509. PubMed ID: 28217982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Folate-mediated delivery of macromolecular anticancer therapeutic agents.
    Lu Y; Low PS
    Adv Drug Deliv Rev; 2002 Sep; 54(5):675-93. PubMed ID: 12204598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advancements in folate receptor targeting for anti-cancer therapy: A small molecule-drug conjugate approach.
    Rana A; Bhatnagar S
    Bioorg Chem; 2021 Jul; 112():104946. PubMed ID: 33989916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Folate-conjugated nanoparticles as a potent therapeutic approach in targeted cancer therapy.
    Bahrami B; Mohammadnia-Afrouzi M; Bakhshaei P; Yazdani Y; Ghalamfarsa G; Yousefi M; Sadreddini S; Jadidi-Niaragh F; Hojjat-Farsangi M
    Tumour Biol; 2015 Aug; 36(8):5727-42. PubMed ID: 26142733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms and implications of dual-acting methotrexate in folate-targeted nanotherapeutic delivery.
    Wong PT; Choi SK
    Int J Mol Sci; 2015 Jan; 16(1):1772-90. PubMed ID: 25590303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.